FDA: Low Levels of Cancer-Causing Chemical Found in Zantac
The agency has yet to issue a recall for the popular heartburn medication.

Jason Reed/Reuters
Get the Cheat Sheet newsletter delivered straight to your inbox
By clicking “SIGN UP” you agree to our Terms of Use and Privacy Policy.
The Food and Drug Administration announced it has found low levels of a cancer-causing chemical in heartburn medicine samples containing the drug that’s sold under the brand-name Zantac, The New York Times reports. The agency said it found low levels of a type of nitrosamine called NDMA in the drug, known as ranitidine. NDMA could cause tumors in the liver and other organs in lab animals, and is believed to be carcinogenic in humans. NDMA can form in the drug manufacturing process if chemical reactions used in production aren’t controlled or monitored carefully enough, according to the FDA. Agency spokesman Jeremy Kahn said the FDA was still investigating the contamination and has not identified where it originated or how widespread the issue is. The European Medicines Agency is also looking into the matter.
Unlock a year of full access to The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation
Sign in or create an account
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation